Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets end the day on a high
Mon, 22 Nov Closing

At the end of a buoyant trading session the Indian indices moved into strong positive territory. While BSE Sensex closed higher by around 372 points (up 1.9%), Nifty was up around 120 points (2.0%). Mid and small caps both saw significant buying interest as the BSE-Midcap Index and the BSE-Smallcap indices were both higher by around 1.3% and 1.5% respectively.

All major indices closed in the positive today, with the banking index seeing the maximum gains (up almost 2.6%). Most Asian markets closed mixed today whereas Europe is trading positive currently. The rupee was placed at Rs 45.33 to the dollar at the time of writing.

According to a leading business daily, the Japanese company Honda Motors has made an offer to buy Hero's 26% stake in Hero Honda from the Munjal family. As per earlier reports Hero (the Munjals) had made an offer to buy out Honda's 26% stake earlier. According to the article Honda was unhappy with the offer made by Hero, as it was a 40% discount to current market price. This news has not been confirmed by the company so far.

Leading soda-ash manufacturer Tata Chemicals announced that it has put on hold the Rs 38 bn expansion plan of its urea manufacturing unit at Babrala, Uttar Pradesh. This is due to non-availability of gas, which was scheduled to be allocated by October-November, 2010. The company announced that it will set up two more units to produce nutrient-based fertilisers with an investment of Rs 550 m each, but did not specify where they would be located.

The company stated that it expects capex of around of Rs 4-5 bn in FY11. A 15-18% growth in sales was also expected for the current fiscal, according to the Managing Director.

The entire fertilizer pack was trading lower on a positive day for the Sensex. Chambal Fertilizer and National Fertilizer were among the top losers. The fertilizer department of the government decided not to follow the finance ministry's recommendation for decontrolling urea prices. It has instead decided to go ahead with its former plan to implement the next stage of the new pricing scheme.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Markets end the day on a high". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.